FDA Denies Production of Generic OxyContin

FDA denies production of generic OxyContin
DeWine was one of 48 state and territorial attorneys general who sent a letter to the FDA last month urging them to adopt standards requiring manufacturers and marketers of generic prescription painkillers to develop tamper-and-abuse-resistant versions … Read more on Portsmouth Daily Times